US 7,741,445 B2Granted

Breast cancer resistance protein (BCRP) antibodies

AssigneeUniversity of Maryland, Baltimore

InventorsDouglas D Ross, L. Austin Doyle, Lynne V. Abruzzo

Life of this patent

Estimating the term…

Abstract

The Breast Cancer Resistance Protein is described, as well as the cDNA encoding said protein. This protein has been found to confer resistance to cancer chemotherapeutic drugs.

Claims3

Dependent claims

An isolated polyclonal antibody which binds to the polypeptide of SEQ ID NO:1.

Dependencies are inferred from the claim text.

Facts

Application: 12/060,738Filed 1 Apr 2008 · continuation
Priority: 5 Feb 1998
Published: US 2009/0104199 A123 Apr 2009
Granted: 22 Jun 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

G01N 33/57515
For cancer: of the breast
A61K 31/4985
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrazines or piperazines…
A61P 35/00
Antineoplastic agents
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00

Family

Application60/073,763Us provisional application · filed 5 Feb 1998
Application09/245,808Parent of this division · filed 5 Feb 1999
Application09/961,086Parent of this continuation · filed 21 Sep 2001
US 2009/0104199 A1Pre-grant publication · published 23 Apr 2009
US 7,541,437 B2Parent of this continuation
US 6,313,277 B1Parent of this division
Application09/961,086Parent of this division
US 2003/0036645 A1Published application
US 7,741,445 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results